Zymes Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 126.94%
- Profit Growth 27.82%
- Ebitda 135.17%
- Net Worth 127.91%
- Total Assets 39.15%
About Zymes Bioscience
Zymes Bioscience Private Limited (ZBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 April 2012 and has a history of 12 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shivali Choudhary and Chandan Chopra serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51102DL2012PTC234105
-
Company No.
234105
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Apr 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Zymes Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivali Choudhary
|
Director | 25-May-2022 | Current |
|
Chandan Chopra
|
Director | 01-May-2024 | Current |
Financial Performance of Zymes Bioscience.
Zymes Bioscience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 126.94% increase. The company also saw a substantial improvement in profitability, with a 27.82% increase in profit. The company's net worth Soared by an impressive increase of 127.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zymes Bioscience?
Unlock access to Zymes Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Astrom Bioscience Private LimitedShivali Choudhary and Chandan Chopra are mutual person
-
Biomak Laboratories Private Limited
Shivali Choudhary is a mutual person
-
Zalix Pharmaceuticals Private Limited
Shivali Choudhary is a mutual person
-
Awake Life Sciences Llp
Chandan Chopra is a mutual person
-
Zymes Tech Private Limited
Chandan Chopra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zymes Bioscience?
Zymes Bioscience has a workforce of 51 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zymes Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zymes Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
